University of Minnesota. Driven to Discover.
Researchers used detailed exams in survivors to document eye problems, a common finding.
Cape Verde reported its first Zika illnesses, while Panama and Honduras confirmed additional cases.
Also, a trial in infants of a high-dose type 2 inactivated vaccine candidate shows promise.
The NIH sees its biggest boost in 12 years, and other public health initiatives benefit, too.
The worrisome MCR-1 resistance gene has spread to distant regions, even Africa, rather quickly.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.